Trial participants Table of Contents Trial participants Trial design, treatment and oversight Peptides IFNγ ELISpot assay Characterization of CD4⁺ and CD8⁺ T cell responses In vitro stimulation and functional validation…
The post Neoantigen Vaccine for Lynch Syndrome Cancer Prevention: Phase 1b/2 Trial Results appeared first on News Directory 3.